80 jili download THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) SOURCE AmgenAKRON, Ohio , Dec. 10, 2024 /PRNewswire/ -- BIT Mining Limited (NYSE: BTCM) ("BIT Mining" or the "Company"), a leading technology-driven cryptocurrency mining company, today announced that it will hold its annual general meeting of shareholders at 428 South Seiberling Street, Akron, Ohio , US on January 7, 2025 at 10:00 a.m., New York time. Holders of record of ordinary shares and Class A preference shares of the Company at the close of business on December 20, 2024 , New York time (the "Record Date") are entitled to receive notice of, and to attend and vote at, the annual general meeting or any adjournment thereof. Holders of the Company's American Depositary Shares ("ADSs") who wish to exercise their voting rights for the underlying ordinary shares must act through the depositary of the Company's ADS program, Deutsche Bank Trust Company Americas. The notice of the annual general meeting, which sets forth the resolutions to be submitted to shareholder approval at the annual general meeting is available on the Investor Relations section of the Company's website at https://ir.btcm.group . The Company filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission (the "SEC") on May 15, 2024 . Shareholders may obtain a copy of the Company's annual report, free of charge, from the Company's website at https://ir.btcm.group and on the SEC's website at www.sec.gov , or by contacting BIT Mining Limited at 428 South Seiberling Street, Akron, Ohio , US, attention: Victor He , telephone: +1 (330) 676-2680, email: ir@btcm.group . About BIT Mining Limited BIT Mining (NYSE: BTCM) is a leading technology-driven cryptocurrency mining company with operations in cryptocurrency mining, data center operation and mining machine manufacturing. The Company is strategically creating long-term value across the industry with its cryptocurrency ecosystem. Anchored by its cost-efficient data centers that strengthen its profitability with steady cash flow, the Company also conducts self-mining operations that enhance its marketplace resilience by leveraging self-developed and purchased mining machines to seamlessly adapt to dynamic cryptocurrency pricing. The Company also owns 7-nanometer BTC chips and has strong capabilities in the development of LTC/ DOGE miners and ETC miners. Safe Harbor Statements This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will", "expects", "anticipates", "future", "intends", "plans", "believes", "estimates", "target", "going forward", "outlook" and similar statements. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control, which may cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law. For more information: BIT Mining Limited ir@btcm.group ir.btcm.group www.btcm.group Piacente Financial Communications Victor He Tel: +1 (330) 676-2680 Email: BITMining@thepiacentegroup.com View original content: https://www.prnewswire.com/news-releases/bit-mining-limited-to-hold-annual-general-meeting-on-january-7-2025-302327447.html SOURCE BIT Mining LimitedPitt QB Eli Holstein carted off with leg injuryF5 director Alan Higginson sells $197,810 in stock

Swedish candy faces bizarre global shortage — and influencers may be to blame

Cruise into this holiday season with a non-traditional vacation

BMW praises Tesla's Full Self-Driving technology on social mediaIsraeli strikes without warning in central Beirut kill at least 15 as diplomats push for cease-fire BEIRUT, Lebanon (AP) — Lebanese officials say Israeli airstrikes have killed at least 15 people and injured dozens in central Beirut as the once-rare strikes in the heart of Lebanon’s capital continue without Israeli warning. Diplomats are scrambling to broker a cease-fire but describe the disputed issues that remain. The current proposal calls for a two-month cease-fire during which Israeli forces would withdraw from Lebanon and Hezbollah would end its armed presence along the southern border south of the Litani River. Lebanon’s Health Ministry says Israeli bombardment has killed more than 3,500 people in Lebanon in the months of fighting that have turned into all-out war. Trump raced to pick many Cabinet posts. He took more time to settle on a treasury secretary WASHINGTON (AP) — President-elect Donald Trump launched a blitz of picks for his Cabinet, but he took his time settling on billionaire investor Scott Bessent as his choice for treasury secretary. The Republican not only wanted someone who jibes with him, but an official who can execute his economic vision and look straight out of central casting while doing so. With his Yale University education and pedigree trading for Soros Fund Management before establishing his own funds, Bessent will be tasked with a delicate balancing act. Trump expects him to help reset the global trade order, enable trillions of dollars in tax cuts, ensure inflation stays in check, manage a ballooning national debt and still keep the financial markets confident. Voters rejected historic election reforms across the US, despite more than $100M push JEFFERSON CITY, Mo. (AP) — Election reform advocates had hoped for a big year at the ballot box. That's because a historic number of states were considering initiatives for ranked choice voting or to end partisan primaries. Instead, voters dealt them big losses in the November elections. Voters in Arizona, Colorado, Idaho, Missouri, Montana, Nevada, Oregon and South Dakota all rejected proposed changes to their voting systems. In Alaska, a proposal to repeal ranked choice voting appears to have narrowly fallen short. The losses in many states came even though election reform supporters raised more than $100 million, easily outpacing opponents. Supporters say they aren't giving up but plan to retool their efforts. The week that upped the stakes of the Ukraine war KYIV, Ukraine (AP) — This past week has seen the most significant escalation in hostilities Ukraine has witnessed since Russia's full-scale invasion and marks a new chapter in the nearly three-year war. It began with U.S. President Joe Biden reversing a longstanding policy by granting Kyiv permission to deploy American longer-range missiles inside Russian territory and ended with Moscow striking Ukraine with a new experimental ballistic weapon that has alarmed the international community and heightened fears of further escalation. Storm dumps record rain in Northern California, while US Northeast deals with winter storms HEALDSBURG, Calif. (AP) — A major storm continues to drop heavy snow and record rain in California, causing small landslides and flooding some streets. Meanwhile on the opposite coast blizzard or winter storm warnings were in effect Saturday for areas spanning from the Northeast to central Appalachia. The storm on the West Coast arrived in the Pacific Northwest earlier this week, killing two people and knocking out power to hundreds of thousands, before moving through Northern California. Forecasters predicted that both coasts would begin to see a reprieve from the storms as the system in the northeast moves into eastern Canada and the one in the West heads south. Even with access to blockbuster obesity drugs, some people don't lose weight Most people taking popular drugs like Ozempic and Wegovy to lose weight have shed significant pounds. But obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust results with the new medications. The response to the drugs varies from person to person and can depend on genetics, hormones and differences in how the brain regulates energy. Undiagnosed medical conditions and some drugs can prevent weight loss. Experts say it can take experimentation to help so-called nonresponders find results. Fighting between armed sectarian groups in restive northwestern Pakistan kills at least 37 people PESHAWAR, Pakistan (AP) — A senior Pakistani police officer says fighting between armed sectarian groups in the country's restive northwest has killed at least 37 people. The overnight violence was the latest to rock Kurram, a district in Khyber Pakhtunkhwa province, and comes days after a deadly gun ambush killed 42 people. The officer said Saturday that armed men torched shops, houses and government property overnight. Gunfire is ongoing between rival tribes. Although Sunnis and Shiites generally live together peacefully in Pakistan, tensions remain in some areas, especially Kurram. These Peruvian women left the Amazon, but their homeland still inspires their songs and crafts LIMA, Peru (AP) — Many Shipibo-Konibo craftswomen migrated from their Indigenous communities in the Amazon to Peru's capital, Lima, in the past few decades. Their ancestors' legacy remains present through their songs and techniques, and some of them have managed to make a living out of their crafts. Textiles, jewelry and paintings convey the culture, worldview and beliefs from the lands where they were born. Doctor at the heart of Turkey's newborn baby deaths case says he was a 'trusted' physician ISTANBUL (AP) — The Turkish doctor at the center of an alleged fraud scheme that led to the deaths of 10 babies says he was a “trusted” physician. Dr. Firat Sari is one of 47 people on trial accused of transferring newborn babies to neonatal units of private hospitals, where they were allegedly kept for prolonged and sometimes unnecessary treatments in order to receive social security payments. Sari said patients were referred to him because people trusted him and he did not bribe anyone involved with Turkey’s emergency medical phone line. Sari, said to be the plot’s ringleader, faces up to 583 years in prison. Hydrate. Make lists. Leave yourself time. And other tips for reducing holiday travel stress Travel, especially during the holiday season, can be stressful. But following some tips from the pros as you prepare for a trip can make for a smoother, less anxious experience. One expert traveler suggests making a list a week before you go of things you need to do and pack. Cross off each item as you complete it during the week. Another tip is to carry your comfort zone with you. That could mean noise-canceling headphones, playlists meant to soothe airport travelers, entertainment and snacks from home. Carry a change of clothes and a phone charger in case of delays. Stay hydrated. Leave extra time. And know your airline's rules. Downloading the airline's app can help with that.

President-elect Donald Trump has made a pivotal move by nominating Brooke Rollins, a former White House aide, as his agriculture secretary. Rollins, currently at the helm of the America First Policy Institute, held a prominent role in Trump's office of American innovation during his initial term. Her nomination awaits confirmation by the Republican-controlled Senate, after which she would replace the current agriculture secretary, Tom Vilsack. The position involves managing an expansive portfolio, including farming, forestry, ranching, and food quality policies. (With inputs from agencies.)None